Epidermal Cytokines and the Induction of Allergic and Non-Allergic Contact Dermatitis

  • Ian Kimber
  • Rebecca J. Dearman
  • Marie Cumberbatch
Conference paper
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 19)

Abstract

The term contact dermatitis describes the local cutaneous inflammatory reaction provoked by skin exposure to certain chemicals. Some materials have the potential directly to induce irritant reactions at the site of contact. Alternatively, the appearance of contact dermatitis may reflect an allergic reaction. Following primary exposure of susceptible individuals to a contact allergen an immune response is initiated that results in long-lived allergic sensitization. If the sensitized individual is exposed subsequently to the same chemical allergen then a more aggressive secondary immune response is elicited that results in the manifestation of allergic contact dermatitis. Clearly some chemicals are able to cause both irritant and allergic contact dermatitis; the operational distinction being that such agents are likely to induce allergic reactions in sensitized individuals at concentrations below those that are necessary for the development of irritant responses in individuals who are not sensitized. The purpose of this article is to consider the roles epidermal cytokines play in the induction of contact dermatitis, and in particular their influence on the behaviour of epidermal Langerhans cells and immunological processes.

Keywords

Nickel Migration Acetone Albumin Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aragne Y, Riemann H, Bhardwaj RS, Schwarz A, Sawada Y, Yamada H, Luger T, Kubin M, Trinchieri G, Schwarz T (1994) IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. J Immunol 153:5366–5372.Google Scholar
  2. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD (1995) IL-10 inhibits tumour antigen presentation by epidermal antigen-presenting cells. J Immunol 154:1280–1286.PubMedGoogle Scholar
  3. Berg DJ, Leach MW, Kuhn R, Rajewsky K, Muller W, Davidson NJ, Rennick D (1995) Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med 182:99–108.PubMedCrossRefGoogle Scholar
  4. Blauvelt A, Asada H, Klaus-Kovtun A, Altman DJ, Lucey DR, Katz SI (1996) Interleukin-15 mRNA is expressed by human keratinocytes, Langerhans cells, and blood-derived dendritic cells and is downregulated by ultraviolet B radiation. J Invest Dermatol 106:1047–1052.PubMedCrossRefGoogle Scholar
  5. Chang C-H, Furue M, Tamaki K (1995) B7–1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-γ or by interleukin-10. Eur J Immunol 25:394–398.PubMedCrossRefGoogle Scholar
  6. Cumberbatch M, Dearman RJ, Kimber I (1996) Constitutive and inducible expression of interleukin-6 by Langerhans cells and lymph node dendritic cells. Immunology 87:513–518.PubMedCrossRefGoogle Scholar
  7. Cumberbatch M, Fielding I, Kimber I (1994) Modulation of epidermal Langerhans cell frequency by tumour necrosis factor-α. Immunology 81:395–401.PubMedGoogle Scholar
  8. Cumberbatch M, Fielding I, Kimber I (1995) Epidermal Langerhans cell migration: signals and mechanisms. In: Banchereau J, Schmitt D (eds) Dendritic Cells in Fundamental and Clinical Immunology, Volume 2. Plenum Press, New York, pp i73–175.Google Scholar
  9. Cumberbatch M, Kimber I (1992) Dermal tumour necrosis factor- α induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans cell migration. Immunology 75:257–263.PubMedGoogle Scholar
  10. Cumberbatch M, Kimber I (1995) Tumour necrosis factor- α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84:31–35.PubMedGoogle Scholar
  11. Cumberbatch M, Scott RC, Basketter DA, Scholes EW, Hilton J, Dearman RJ, Kimber I (1993) Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation. Toxicology 77:181–191.PubMedCrossRefGoogle Scholar
  12. Dearman RJ, Basketter DA, Kimber I (1995) Differential cytokine production following chronic exposure of mice to chemical respiratory and contact allergens. Immunology 86:545–550.PubMedGoogle Scholar
  13. Dearman RJ, Kimber I (1991) Differential stimulation of immune function by, respiratory and contact chemical allergens. Immunology 72:563–570.PubMedGoogle Scholar
  14. Dearman RJ, Kimber I (1992) Divergent immune responses to respiratory and contact chemical allergens: antibody elicited by phthalic anhydride and oxazolone. Clin Exp Allergy 22:241–250.PubMedCrossRefGoogle Scholar
  15. Enk AH, Angeloni VL, Udey MC, Katz SI (1993a) An essential role for Langerhans cell-derived IL-iβ in the initiation of primary immune responses in the skin. J Immunol 150:3698–3704.PubMedGoogle Scholar
  16. Enk AH, Angeloni VL, Udey MC, Katz SI (1993b) Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in the induction of tolerance. J Immunol 151:2390–2398.PubMedGoogle Scholar
  17. Enk AH, Katz SI (1992a) Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89:1398–1402.PubMedCrossRefGoogle Scholar
  18. Enk AH, Katz SI (1992b) Identification and induction of keratinocyte-derived IL-10. J Immunol 149:92–95.PubMedGoogle Scholar
  19. Gruschwitz MS, Hornstein OP (1992) Expression of transforming growth factor type beta on human epidermal dendritic cells. J Invest Dermatol 99:114–116.PubMedCrossRefGoogle Scholar
  20. Heufler C, Koch F, Schuler G (1988) Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 167:700–705.PubMedCrossRefGoogle Scholar
  21. Heufler C, Koch F, Stanzi U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuier G (1996) Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-y production by T helper 1 cells. Eur J Immunol 26:659–668.PubMedCrossRefGoogle Scholar
  22. Heufler C, Topar G, Grasseger A, Stanzi U, Koch F, Romani N, Namen AE, Schuier G (1993) Interleukin 7 is produced by murine and human keratinocytes. J Exp Med 178:1109–1114.PubMedCrossRefGoogle Scholar
  23. Heufler C, Topar G, Koch F, Trockenbacher B, Kampgen E, Romani N, Schuler G (1992) Cytokine gene expression in murine epidermal cell suspensions: interleukin iβ and macrophage inflammatory protein iα are selectively expressed in Langerhans cells but are differentially regulated in culture. J Exp Med 176:1221–1226.PubMedCrossRefGoogle Scholar
  24. Holliday MR, Dearman RJ, Basketter DA, Kimber I (1996) Stimulation by oxazolone of increased IL-6, but not IL-10, in the skin of mice. Toxicology 106:237–242.PubMedCrossRefGoogle Scholar
  25. Howie SEM, Aldridge RD, McVittie E, Forsey RJ, Sands C, Hunter JAA (1996) Epidermal keratinocyte production of interferon-γ immunoreactive protein and mRNA is an early event in allergic contact dermatitis. J Invest Dermatol 106:1218–1223.PubMedCrossRefGoogle Scholar
  26. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH (1996) IL-12 synthesis by human Langerhans cells. J Immunol 156:1402–1407.PubMedGoogle Scholar
  27. Kapsenberg ML, Wierenga EA, Bos JD, Jansen HM (1991) Functional subsets of allergen-reactive human CD4+ T cells. Immunol Today 12:392–395.PubMedCrossRefGoogle Scholar
  28. Kapsenberg ML, Wierenga EA, Stiekma FEM, Tiggelman AMBC, Bos JD (1992) TH1 lymphokine production profiles of nickel-specific CD4+ T lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 98:59–63.PubMedCrossRefGoogle Scholar
  29. Kimber I (1994) Cytokines and the regulation of allergic sensitization to chemicals. Toxicology 93:1–11.PubMedCrossRefGoogle Scholar
  30. Kimber I, Cumberbatch M (1992) Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol Appl Pharmacol 117:137–146.PubMedCrossRefGoogle Scholar
  31. Kimber I, Cumberbatch M (1995) Langerhans cell migration: initiation and regulation. In Moll H (ed) The Immune Functions of Epidermal Langerhans Cells, R G Landes Co, Austin, pp103–117.Google Scholar
  32. Kimber I, Dearman RJ (1996) Contact hypersensitivity: immunological mechanisms. In Kimber I, Maurer T (eds) Toxicology of Contact Hypersensitivity, Taylor and Francis, London, pp4–25.Google Scholar
  33. Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA (1990) Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 172:1609–1614.PubMedCrossRefGoogle Scholar
  34. Kondo S, McKenzie RC, Sauder DN (1994) Interleukin 10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 103:811–814.PubMedCrossRefGoogle Scholar
  35. Li L, Elliott JF, Mosmann TR, (1994) IL-10 inhibits cytokine production, vascular leakage and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J Immunol 153:3967–3978.PubMedGoogle Scholar
  36. Macatonia SE, Doherty TM, Knight SC, O’Garra A (1993) Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-γ production. J Immunol 150:3755–3765.PubMedGoogle Scholar
  37. Maguire HC Jr (1995) Murine recombinant interleukin-12 increases the acquisition of allergic contact dermatitis in the mouse. Int Arch Allergy Immunol 106:166–168.PubMedCrossRefGoogle Scholar
  38. Manetti R, Parronchi P, Guidizi MG, Piccinni M-P, Maggi G, Trinchieri G, Romagnani S (1993) Natural killer cell stimulatory factor (interleukin 12 (IL-12)) induces T helper type 1 (Th1)-specific immune responses and inhibits development of IL-4 producing Th cells. J Exp Med 177:1199–1204.PubMedCrossRefGoogle Scholar
  39. Matsue H, Cruz PD Jr, Bergstresser PR, Takashima A (1992) Langerhans cells are the major source of mRNA for IL-Iβ and MlP-iα among unstimulated mouse epidermal cells. J Invest Dermatol 99:537–541.PubMedCrossRefGoogle Scholar
  40. Mohamadzadeh M, Poltorak AN, Bergstresser PR, Beutler B, Takashima A (1996) Dendritic cells produce macrophage inflammatory protein-iγ, a new member of the CC chemokine family. J Immunol 156:3102–3106.PubMedGoogle Scholar
  41. Moodycliffe AM, Kimber I, Norval M (1992) The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology 77:394–399.PubMedGoogle Scholar
  42. Moodycliffe AM, Kimber I, Norval M (1994) Role of tumour necrosis factor-α in ultraviolet B light-induced dendritic cell migration and suppression of contact hypersensitivity. Immunology 81:79–84.PubMedGoogle Scholar
  43. Nakamura K, Williams IR, Kupper TS (1995) Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J Invest Dermatol 105:635–643.PubMedCrossRefGoogle Scholar
  44. Ozawa H, Aiba S, Nakagawa S, Tagami H (1996a) Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7–1) expression. Eur J Immunol 26: 648–652.PubMedCrossRefGoogle Scholar
  45. Ozawa H, Nakagawa S, Tagami H, Aiba S (1996b) Interleukin-iβ and granulocyte macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol 106:441–445.PubMedCrossRefGoogle Scholar
  46. Peguet-Navarro J, Moulon C, Caux C, Dalbiez-Gauthier C, Banchereau J, Schmitt D (1994) Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur J Immunol 24:884–891.PubMedCrossRefGoogle Scholar
  47. Picut CA, Lee CS, Dougherty EP, Anderson KI, Lewis RM (1988) Immunostimulatory capabilities of highly enriched Langerhans cells in vitro. J Invest Dermatol 90:201–206.PubMedCrossRefGoogle Scholar
  48. Schmitt E, Hoehn P, Huels C, Goedert S, Palm N, Rude E, Germann T (1994) T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. Eur J Immunol 24:793–798.PubMedCrossRefGoogle Scholar
  49. Schreiber S, Kilgus O, Payer E, Kutil R, Elbe A, Mueller C, Stingi G (1992) Cytokine pattern of Langerhans cells isolated from murine epidermal cell cultures. J Immunol 149:3525–3534.Google Scholar
  50. Schroder J-M (1995) Cytokine networks in the skin. J Invest Dermatol 105:20S–24SPubMedCrossRefGoogle Scholar
  51. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Ferguson TA, Chaplin DD (1996) Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med 183:1427–1436.PubMedCrossRefGoogle Scholar
  52. Trinchieri G (1994) Interleukin-12 and its role in the generation of Th-1 cells. Immunol Today 14:335–337.CrossRefGoogle Scholar
  53. Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM (1987) Granulocyte/macrophage colony-stimulating factor is essential for the viability and, function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484–1498.PubMedCrossRefGoogle Scholar
  54. Yawalkar N, Limat A, Brand CU, Braathen LR (1996) Constitutive expression of both subunits of interleukin-12 in human keratinocytes. J Invest Dermatol 106:80–83.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • Ian Kimber
    • 1
  • Rebecca J. Dearman
    • 1
  • Marie Cumberbatch
    • 1
  1. 1.Zeneca Central Toxicology LaboratoryCheshireUK

Personalised recommendations